The Treatment of Menstrually-Related Mood Disorders With Extended Versus Interrupted Oral Contraceptives.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Drospirenone/ethinylestradiol; Ulipristal
- Indications Premenstrual dysphoric disorder
- Focus Therapeutic Use
- 25 Aug 2017 Biomarkers information updated
- 06 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 06 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.